0000000000188393

AUTHOR

Jacob Raber

showing 2 related works from this author

Statistical analysis of latency outcomes in behavioral experiments

2011

In experimental designs of animal models, memory is often assessed by the time for a performance measure to occur (latency). Depending on the cognitive test, this may be the time it takes an animal to escape to a hidden platform (water maze), an escape tunnel (Barnes maze) or to enter a dark component (passive avoidance test). Latency outcomes are usually statistically analyzed using ANOVAs. Besides strong distributional assumptions, ANOVA cannot properly deal with animals not showing the performance measure within the trial time, potentially causing biased and misleading results. We propose an alternative approach for statistical analyses of latency outcomes. These analyses have less distr…

Spatial BehaviorMorris water navigation taskWater mazeBehavioral neuroscienceMachine learningcomputer.software_genreArticleDevelopmental psychologyBehavioral NeuroscienceAvoidance LearningReaction TimeAnimalsLatency (engineering)Maze Learningbusiness.industryRetention PsychologyBarnes mazeCognitive testSample size determinationData Interpretation StatisticalSample SizeModels AnimalData DisplayAnalysis of varianceArtificial intelligencePsychologybusinesscomputerBehavioural Brain Research
researchProduct

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling

2020

The farnesoid X receptor (FXR) plays a critical role in the regulation of lipid and bile acid (BA) homeostasis. Hepatic FXR loss results in lipid and BA accumulation, and progression from hepatic steatosis to nonalcoholic steatohepatitis (NASH). This study aimed to evaluate the effects of xanthohumol (XN), a hop-derived compound mitigating metabolic syndrome, on liver damage induced by diet and FXR deficiency in mice. Wild-type (WT) and liver-specific FXR-null mice (FXRLiver−/−) were fed a high-fat diet (HFD) containing XN or the vehicle formation followed by histological characterization, lipid, BA and gene profiling. HFD supplemented with XN resulted in amelioration of hepatic steatosis a…

0301 basic medicinenonalcoholic fatty liver diseasemedicine.medical_specialtymedicine.drug_classRM1-95003 medical and health scienceschemistry.chemical_compound0302 clinical medicineGlucocorticoid receptorInternal medicineConstitutive androstane receptorlipid metabolismmedicinePharmacology (medical)Original ResearchPharmacologybile acidsPregnane X receptorBile acidChemistryLipid metabolismmedicine.diseasexanthohumol030104 developmental biologyEndocrinologyXanthohumol030211 gastroenterology & hepatologyFarnesoid X receptorTherapeutics. PharmacologySteatosisfarnesoid X receptorFrontiers in Pharmacology
researchProduct